Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited (KIMS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

kimshospitals.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹767.85
Market cap
30,640 Cr
Stock P/E
175.8
P/B
12.03
Dividend yield
0.7%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales652 Cr606 Cr634 Cr688 Cr777 Cr772 Cr797 Cr872 Cr961 Cr998 Cr1,075 Cr1,180 Cr
Operating expenses (approx.)475 Cr459 Cr475 Cr509 Cr559 Cr585 Cr599 Cr679 Cr757 Cr799 Cr868 Cr956 Cr
EBITDA177 Cr147 Cr159 Cr179 Cr218 Cr187 Cr198 Cr193 Cr204 Cr199 Cr207 Cr223 Cr
OPM %27.2%24.3%25.1%26.1%28.1%24.2%24.8%22.1%21.2%19.9%19.2%18.9%
Other income3 Cr3 Cr4 Cr5 Cr5 Cr18 Cr5 Cr7 Cr4 Cr5 Cr10 Cr16 Cr
Interest9 Cr12 Cr16 Cr18 Cr20 Cr26 Cr27 Cr33 Cr45 Cr57 Cr68 Cr83 Cr
Depreciation33 Cr35 Cr46 Cr39 Cr41 Cr45 Cr53 Cr53 Cr66 Cr79 Cr85 Cr101 Cr
Profit before tax139 Cr102 Cr100 Cr127 Cr162 Cr135 Cr134 Cr114 Cr97 Cr69 Cr55 Cr57 Cr
Tax %26.9%25.3%28.5%25.1%25.6%31.3%20.8%25.2%25.6%24.3%39.6%33.9%
Net profit101 Cr77 Cr71 Cr95 Cr121 Cr93 Cr106 Cr85 Cr72 Cr52 Cr33 Cr37 Cr
EPS (₹)₹11.50₹8.98₹8.18₹10.82₹2.68₹2.22₹2.54₹1.96₹1.67₹1.33₹1.06₹1.04

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,330 Cr1,651 Cr2,198 Cr2,498 Cr3,035 Cr3,905 CrSign in for TTM
Operating expenses (approx.)959 Cr1,135 Cr1,594 Cr1,858 Cr2,252 Cr3,103 CrSign in for TTM
EBITDA371 Cr516 Cr604 Cr640 Cr783 Cr802 CrSign in for TTM
OPM %27.9%31.2%27.5%25.6%25.8%20.5%Sign in for TTM
Other income10 Cr20 Cr26 Cr13 Cr32 Cr26 CrSign in for TTM
Interest32 Cr16 Cr31 Cr47 Cr90 Cr203 CrSign in for TTM
Depreciation70 Cr73 Cr129 Cr147 Cr177 Cr283 CrSign in for TTM
Profit before tax279 Cr458 Cr485 Cr460 Cr558 Cr334 CrSign in for TTM
Tax %26.4%25.0%24.6%26.9%25.7%27.5%Sign in for TTM
Net profit205 Cr344 Cr366 Cr336 Cr415 Cr242 CrSign in for TTM
EPS (₹)₹26.87₹41.88₹42.03₹38.75₹9.61₹6.03Sign in for TTM
Dividend payout %—0.0%0.0%0.0%0.0%85.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital78 Cr80 Cr80 Cr80 Cr80 Cr80 Cr
Reserves786 Cr1,307 Cr1,590 Cr1,748 Cr2,058 Cr2,167 Cr
Borrowings240 Cr161 Cr678 Cr1,355 Cr2,557 Cr3,244 Cr
Other liabilities320 Cr336 Cr325 Cr403 Cr761 Cr1,956 Cr
Total liabilities1,436 Cr1,907 Cr2,941 Cr3,852 Cr5,736 Cr7,759 Cr
Fixed assets (net)771 Cr771 Cr1,381 Cr1,730 Cr2,199 Cr4,186 Cr
CWIP9 Cr21 Cr477 Cr600 Cr1,214 Cr606 Cr
Investments51 Cr332 Cr68 Cr157 Cr99 Cr16 Cr
Loans & advances2 Cr0 Cr0 Cr0 Cr48 Cr72 Cr
Inventories24 Cr36 Cr43 Cr49 Cr64 Cr97 Cr
Trade receivables110 Cr129 Cr253 Cr294 Cr395 Cr554 Cr
Cash & bank52 Cr26 Cr62 Cr47 Cr56 Cr55 Cr
Other assets417 Cr593 Cr659 Cr974 Cr1,661 Cr2,172 Cr
Total assets1,436 Cr1,907 Cr2,941 Cr3,852 Cr5,736 Cr7,759 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—520 Cr432 Cr521 Cr582 Cr511 Cr
Cash from investing—-606 Cr-616 Cr-753 Cr-1,116 Cr-1,452 Cr
Cash from financing—60 Cr88 Cr217 Cr543 Cr940 Cr
Net cash flow—-26 Cr-95 Cr-15 Cr9 Cr-0.60 Cr
Free cash flow (OCF − Capex)—350 Cr-142 Cr-126 Cr-427 Cr-917 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %27.9%30.2%19.7%14.7%13.0%9.2%
ROE %23.0%27.5%17.4%14.8%15.9%9.4%
Debtor days302842434752
Inventory days3187789
Days payable1702929293230
Cash conversion cycle-109820212331
Debt / equity0.280.000.410.741.201.44
Current ratio1.621.831.611.310.830.76
Net debt / EBITDA0.000.001.022.043.193.98

Compare with peers

Loading peers…